➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Colorcon
Merck
McKinsey
McKesson

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Claims for Patent: 8,718,193


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,718,193
Title:Active signal processing personal health signal receivers
Abstract: The invention provides a receiver associated with a body, e.g., located inside or within close proximity to a body, configured to receive and decode a signal from an in vivo transmitter which located inside the body. Signal receivers of the invention provide for accurate signal decoding of a low-level signal, even in the presence of significant noise, using a small-scale chip, e.g., where the chip consumes very low power. Also provided are systems that include the receivers, as well as methods of using the same.
Inventor(s): Arne; Lawrence (Redwood City, CA), Au-Yeung; KitYee (San Francisco, CA), Crandall; Kenneth C. (Sunnyvale, CA), Robertson; Timothy (Belmont, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:12/515,527
Patent Claims: 1. A signal receiver, comprising: (a) a receiver module configured to receive an encoded signal from an in vivo transmitter in a low signal to noise ratio (SNR) environment, the receiver module comprising: a first demodulator to receive the encoded signal and to produce a filtered complex baseband signal; a carrier frequency detector to receive the filtered complex baseband signal and generate an estimated carrier offset frequency; a second demodulator to receive the complex baseband signal and the estimated carrier offset frequency and to produce a demodulated encoded signal; and (b) a decoder module coupled to the receiver module to receive the demodulated encoded signal, the decoder module configured to decode the demodulated encoded signal with substantially no error; wherein the signal receiver is sized to be stably associated with a living subject in a manner that does not substantially impact movement of the living subject, wherein the first demodulator comprises: a first mixer; a direct digital synthesizer coupled to the first mixer to produce a nominal carrier frequency, wherein the received encoded signal is mixed by the mixer with the nominal carrier frequency to produce the complex baseband signal; and a first low pass filter coupled to the first mixer to filter the complex baseband signal.

2. The signal receiver according to claim 1, further comprising a decimation block coupled to the first low pass filter.

3. A signal receiver, comprising: (a) a receiver module configured to receive an encoded signal from an in vivo transmitter in a low signal to noise ratio (SNR) environment, the receiver module comprising: a first demodulator to receive the encoded signal and to produce a complex baseband signal; a carrier frequency detector to receive the filtered complex baseband signal and generate an estimated carrier offset frequency; a second demodulator to receive the complex baseband signal and the estimated carrier offset frequency and to produce a demodulated encoded signal; and (b) a decoder module coupled to the receiver module to receive the demodulated encoded signal, the decoder module configured to decode the demodulated encoded signal with substantially no error; wherein the signal receiver is sized to be stably associated with a living subject in a manner that does not substantially impact movement of the living subject, wherein the second demodulator comprises: a second mixer to mix the filtered complex baseband signal with the estimated carrier offset frequency; and a second low pass filter coupled to the second mixer to produce the demodulated encoded signal.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Harvard Business School
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.